Risedronate superior to alendronate in hip fracture reduction: REAL

20 June 2008 Print this article Comments Share this article
Regardless of fracture history, risedronate treatment is superior to alendronate in terms of hip fracture reduction during the first year of therapy, according to a sub-group analysis of the REAL study presented at ECTS 2008. Australian rheumatologist Dr Charles Inderjeeth (Perth) summarises the findings....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites